Quick Answer
IDEXX LABORATORIES INC /DE reported Operating Income of $1.36 billion for fiscal year 2025.
IDEXX LABORATORIES INC /DE Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.36B | +20.5% |
| 2024 | $1.13B | +2.8% |
| 2023 | $1.10B | +22.1% |
| 2022 | $898.76M | -3.6% |
| 2021 | $932.03M | +34.2% |
| 2020 | $694.52M | +25.6% |
| 2019 | $552.85M | +12.5% |
| 2018 | $491.33M | +19.0% |
| 2017 | $413.03M | +17.9% |
| 2016 | $350.24M | +16.8% |
| 2015 | $299.91M | +15.2% |
| 2014 | $260.25M | -2.4% |
| 2013 | $266.76M | +1.6% |
| 2012 | $262.56M | +11.1% |
| 2011 | $236.22M | +15.9% |
| 2010 | $203.88M | +15.9% |
| 2009 | $175.97M | +2.0% |
| 2008 | $172.46M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $354.85M | +16.8% | -4.9% |
| June 30, 2025 | $373.05M | +41.4% | +17.9% |
| March 31, 2025 | $316.53M | +5.9% | +4.2% |
| September 30, 2024 | $303.89M | +10.4% | +15.2% |
| June 30, 2024 | $263.80M | -10.9% | -11.8% |
| March 31, 2024 | $298.96M | +6.6% | +8.6% |
| September 30, 2023 | $275.28M | +12.4% | -7.0% |
| June 30, 2023 | $296.14M | +65.4% | +5.6% |
- IDEXX LABORATORIES INC /DE showed an increase of +20.5% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, IDEXX LABORATORIES INC /DE’s operating income has grown by 688.6% (from $172.46 million to $1.36 billion).
- The most recent figure is from IDEXX LABORATORIES INC /DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: